Roche publishes PhI data for KRAS drug in NEJM paper as it chases Amgen, Mirati - Endpoints News
endpts.comSubmitted by endpointsnews6292 in business
On a quest not just to catch up with, but leapfrog, Amgen and Mirati in the KRAS race, Roche has released early monotherapy data on its in-house candidate across a variety of cancers. Roche, which presented some divarasib data at the AACR conference in April,…